江苏创源生命科技

Jiangsu Chuangyuan Life Science is a biotechnology company headquartered in Nanjing, China, dedicated to the advancement of regenerative medicine and cell-based therapies. The company operates the Nanjing Regional Cell Resource Bank and a state-of-the-art GMP-compliant cell preparation center. Its primary focus lies in the research, development, and clinical application of mesenchymal stem cells (MSCs) and immune cells, such as Natural Killer (NK) cells. Chuangyuan provides comprehensive services including cell storage, quality evaluation, and the development of therapeutic candidates for various degenerative and immune-related conditions. Through collaborations with leading medical institutions, the company aims to bridge the gap between laboratory research and clinical practice in the field of precision medicine. The firm is a key participant in regional biotechnology initiatives, contributing to the standardization of cell therapy production in Jiangsu province.